Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 5

Results: 10

Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 685, doi. 10.1002/ddr.21774
By:
- Ortega‐Vázquez, Alberto;
- Mayen‐Lobo, Yerye G.;
- Dávila‐Ortiz de Montellano, David J.;
- Tristán‐López, Luis;
- Aviña‐Cervantes, Carlos L.;
- Ríos, Camilo;
- López‐López, Marisol;
- Monroy‐Jaramillo, Nancy
Publication type:
Article
Issue Information.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 617, doi. 10.1002/ddr.21694
Publication type:
Article
Lithium treatment in the era of personalized medicine.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 621, doi. 10.1002/ddr.21660
Publication type:
Article
Personalized treatments in neuropsychiatric disorders.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 618, doi. 10.1002/ddr.21854
Publication type:
Article
Effect of non‐invasive brain stimulation on behavior and serum brain‐derived neurotrophic factor and insulin‐like growth factor‐1 levels in autistic patients.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 716, doi. 10.1002/ddr.21808
By:
- Robinson‐Agramonte, Maria de los Angeles;
- Michalski, Bernadeta;
- Fernández, Lázaro Gomez;
- Vidal‐Martinez, Belkis;
- Cuesta, Hector Vera;
- Rizo, Carlos Maragoto;
- Fahnestock, Margaret
Publication type:
Article
Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 707, doi. 10.1002/ddr.21798
By:
- Sánchez, Reinier Cardentey;
- de la Fe, Amado Díaz;
- Suarez, Alejandro Peláez;
- Grass, Dayme;
- Vega, Teresa Morgado;
- Canal, Armando Sánchez;
- Siniscalco, Dario;
- de los Angeles Robinson Agramonte, María
Publication type:
Article
Biomarkers to predict staging and treatment response in opioid dependence: A narrative review.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 668, doi. 10.1002/ddr.21789
By:
- Vorspan, Florence;
- Marie‐Claire, Cynthia;
- Bellivier, Frank;
- Bloch, Vanessa
Publication type:
Article
Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 695, doi. 10.1002/ddr.21784
By:
- Cacabelos, Ramón;
- Carrera, Iván;
- Martínez, Olaia;
- Naidoo, Vinogran;
- Cacabelos, Natalia;
- Aliev, Gjumrakch;
- Carril, Juan C.
Publication type:
Article
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 628, doi. 10.1002/ddr.21778
By:
- Fanni, Daniela;
- Pinna, Federica;
- Gerosa, Clara;
- Paribello, Pasquale;
- Carpiniello, Bernardo;
- Faa, Gavino;
- Manchia, Mirko
Publication type:
Article
Schizophrenia‐associated gene dysbindin‐1 and tardive dyskinesia.
Published in:
Drug Development Research, 2021, v. 82, n. 5, p. 678, doi. 10.1002/ddr.21681
By:
- Maes, Miriam S.;
- Lu, Justin Y.;
- Tiwari, Arun K.;
- Freeman, Natalie;
- de Luca, Vincenzo;
- Müller, Daniel J.;
- Voineskos, Aristotle N.;
- Potkin, Steven G.;
- Lieberman, Jeffrey A.;
- Meltzer, Herbert Y.;
- Remington, Gary;
- Kennedy, James L.;
- Zai, Clement C.
Publication type:
Article